Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases
Authors:
- 1 October 2021
- journal article
- research article
- Published by Elsevier in The Lancet Rheumatology
- Vol. 3 (10) , e707-e714
Abstract
No abstract availableKeywords
Funding Information
- Novartis
- Department of Health, Disability and Ageing
- Meso Scale Diagnostics
- Roche
- European League Against Rheumatism
- Vasculitis Foundation
- Sanofi
- Cilag
- Gilead Sciences
- Vasculitis Clinical Research Consortium
- Biogen
- Pfizer
- National Institute for Health and Care Research
- AbbVie
- American College of Rheumatology Research Foundation
This publication has 26 references indexed in Scilit:
- Hydroxychloroquine shortages during the COVID-19 pandemicAnnals of the Rheumatic Diseases, 2021
- Capturing Patient‐Reported Outcomes During the COVID‐19 Pandemic: Development of the COVID‐19 Global Rheumatology Alliance Patient Experience SurveyArthritis Care & Research, 2020
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateAnnals of the Rheumatic Diseases, 2020
- Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registriesThe Lancet Rheumatology, 2020
- US AND UK LABOUR MARKETS BEFORE AND DURING THE COVID-19 CRASHNational Institute Economic Review, 2020
- GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in researchBMJ, 2017
- Framework for Advancing the Reporting of Patient Engagement in Rheumatology Research ProjectsCurrent Rheumatology Reports, 2017
- Recruiting for health, medical or psychosocial research using Facebook: Systematic reviewInternet Interventions, 2016
- Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score With 28‐Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score‐II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index‐5 (RADAI‐5), Chronic Arthritis Systemic Index (CASI), Patient‐Based Disease Activity Score With ESR (PDAS1) and Patient‐Based Disease Activity Score Without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI‐RA)Arthritis Care & Research, 2011
- Frequency of infection in patients with rheumatoid arthritis compared with controls: A population‐based studyArthritis & Rheumatism, 2002